2021 / 04

Next Paper
DOI: 10.24075/medet.2021.027

OPINION

Drug repositioning: lessons from the COVID-19 pandemic

Poroykov VV
About authors

Orekhovich Institute of Biomedical Chemistry, Moscow, Russia

Correspondence should be addressed: Vladimir V. Poroikov
Pogodinskaya, ul., 10, Str. 8, Moscow, 119121, Russia; ur.ksm.cmbi@vokiorop.rimidalv

About paper

Acknowledgement: the study is supported by the Ministry of Science and Higher Education of the Russian Federation in the framework of the Interdepartmental Working Group on the Development of Drugs with Direct Antiviral Activity against SARS-CoV-2 (project No. 121102900156–6).

Received: 2021-10-16 Accepted: 2021-11-27 Published online: 2021-12-30
|